Abstract
O1 - Is semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting in the phase II hypo-FLAME 2.0 trial associated with acceptable acute toxicity?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have